| Literature DB >> 19696938 |
Ewa Siemieniuk1, Lidia Kolodziejczyk, Elżbieta Skrzydlewska.
Abstract
The aim of this paper was to assess the influence of Fasciola hepatica infection on oxidative modifications of rat liver cell components such as proteins and lipids. Wistar rats were infected per os with 30 metacercariae of F. hepatica. Activities and concentrations of liver damage markers were determined in the 4th, 7th, and 10th week postinfection (wpi). A decrease in antioxidant capacity of the host liver, manifested by a decrease in total antioxidant status (TAS), was observed. Diminution of antioxidant abilities resulted in enhanced oxidative modifications of lipids and proteins. F. hepatica infection enhanced lipid peroxidation, which was visible in the statistically significant increase in the level of different lipid peroxidation products such as conjugated dienes (CDs), lipid hydroperoxides (LOOHs), malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). The level of protein modification markers in the rat liver was also significantly changed and the most intensified changes were observed at seventh week postinfection. Concentration of carbonyl groups and dityrosine was significantly increased, whereas the level of tryptophan and sulfhydryl and amino groups was decreased. Changes in the antioxidant abilities of the liver and in the lipid and protein structure of the cell components resulted in destruction of the function of the liver. F. hepatica infection was accompanied by raising serum activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as markers of liver damage. A significant decrease in lysosomal as well as in the total activity of cathepsin B during fasciolosis was also observed.Entities:
Year: 2008 PMID: 19696938 PMCID: PMC2728573 DOI: 10.1080/15376510701624001
Source DB: PubMed Journal: Toxicol Mech Methods ISSN: 1537-6516 Impact factor: 2.987
TAS in the liver of control and F. hepatica-infected rats at 4, 7, and 10 wpi
| Weeks postinfection | ||||||
|---|---|---|---|---|---|---|
| 4 | 7 | 10 | ||||
| Control rats | Infected rats | Control rats | Infected rats | Control rats | Infected rats | |
| TAS mol/g tissue | 110.6 ± 6.5 | 93.5 ± 7.3 | 108.2 ± 6.9 | 91.4 ± 7.5 | 112.5 ± 6.1 | 98.8 ± 7.7 |
Significantly different from control group (p <0.05).
The levels of lipid peroxidation products: conjugated dienes (CDs) lipid hydroperoxides (LOOHs), malondialdehyde (MDA), and 4-hydroxynonenal (4-HNE) in the liver of control and F. hepatica-infected rats at 4, 7, and 10 wpi
| Weeks postinfection | ||||||
|---|---|---|---|---|---|---|
| 4 | 7 | 10 | ||||
| Control rats | Infected rats | Control rats | Infected rats | Control rats | Infected rats | |
| CD (μmol/g tissue) | 1.27 ± 0.05 | 1.34 ± 0.12 | 1.30 ± 0.06 | 1.39 ± 0.14 | 1.29 ± 0.06 | 1.48 ± 0.14 |
| LOOH (μmol/g tissue) | 124 ± 8 | 187 ± 14 | 122 ± 8 | 181 ± 15 | 127 ± 9 | 167 ± 14 |
| MDA (nmol/g tissue) | 2.58 ± 0.15 | 5.09 ± 0.52 | 2.74 ± 0.15 | 4.79 ± 0.52 | 2.71 ± 0.15 | 4.58 ± 0.52 |
| 4-HNE (nmol/g tissue) | 1.36 ± 0.08 | 2.84 ± 0.29 | 1.27 ± 0.08 | 2.53 ± 0.23 | 1.32 ± 0.23 | 2.28 ± 0.23 |
Significantly different from control group (p < 0.05).
The levels of protein modification markers: carbonyl groups, dityrosine, tryptophan, sulfhydryl groups, and amino groups in the liver of control and F. hepatica-infected rats at 4, 7, and 10 wpi
| Weeks postinfection | ||||||
|---|---|---|---|---|---|---|
| 4 | 7 | 10 | ||||
| Control rats | Infected rats | Control rats | Infected rats | Control rats | Infected rats | |
| Carbonyl groups (nmol/mg protein) | 0.97 ± 0.05 | 1.17 ± 0.08 | 0.99 ± 0.06 | 1.32 ± 0.09 | 0.97 ± 0.06 | 1.35 ± 0.11 |
| Dityrosine (U/mg protein) | 0.36 ± 0.02 | 0.46 ± 0.04 | 0.34 ± 0.02 | 0.57 ± 0.05 | 0.40 ± 0.03 | 0.52 ± 0.04 |
| Tryptophan (U/mg protein) | 7.91 ± 0.45 | 7.43 ± 0.58 | 7.95 ± 0.51 | 7.19 ± 0.63 | 8.01 ± 0.55 | 7.42 ± 0.67 |
| Sulfhydryl groups (nmol/mg protein) | 4.11 ± 0.25 | 3.59 ± 0.31 | 4.07 ± 0.27 | 3.24 ± 0.30 | 4.09 ± 0.27 | 3.47 ± 0.30 |
| Amino groups (nmol Tyr/mg protein) | 47.2 ± 3.0 | 42.1 ± 3.1 | 47.6 ± 2.9 | 37.5 ± 3.1 | 46.1 ± 3.1 | 39.1 ± 3.3 |
Significantly different from control group (p < 0.05).
Activity of cathepsin B (pNA, μmol/g tissue) in the liver homogenate, cytosol, and lysosomes of control and F. hepatica-infected rats at 4, 7, and 10 wpi
| Weeks postinfection | ||||||
|---|---|---|---|---|---|---|
| 4 | 7 | 10 | ||||
| Localization | Control rats | Infected rats | Control rats | Infected rats | Control rats | Infected rats |
| Homogenate | 1.87 ± 0.12 | 1.54 ± 0.13 | 1.84 ± 0.11 | 1.42 ± 0.12 | 1.89 ± 0.12 | 1.61 ± 0.14 |
| Cytoso | l0.22 ± 0.02 | 0.32 ± 0.03 | 0.22 ± 0.02 | 0.47 ± 0.04 | 0.22 ± 0.02 | 0.37 ± 0.03 |
| Lysosomes | 1.65 ± 0.09 | 0.99 ± 0.08 | 1.65 ± 0.09 | 0.95 ± 0.08 | 1.65 ± 0.09 | 1.24 ± 0.10 |
Significantly different from control group (p < 0.05).
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities in the serum of control and F. hepatica-infected rats at 4, 7, and 10 wpi
| Weeks postinfection | ||||||
|---|---|---|---|---|---|---|
| 4 | 7 | 10 | ||||
| Control rats | Infected rats | Control rats | Infected rats | Control rats | Infected rats | |
| ALT (U/L) | 32.6 ± 1.4 | 93.7 ± 6.9 | 34.5 ± 1.4 | 96.1 ± 6.9 | 33.4 ± 1.6 | 98.3 ± 4.7 |
| AST (U/L) | 162.1 ± 6.5 | 357.1 ± 26.7 | 167.3 ± 6.5 | 361.8 ± 26.7 | 164.2 ± 6.9 | 359.3 ± 24.6 |
Significantly different from control group (p < 0.05).